A method for the treatment of diabetes mellitus type 2 comprising administering(d) desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof,(e) insulin glargine or/and a pharmaceutically acceptable salt thereof, and(f) metformin or/and a pharmaceutically acceptable salt thereof,to a subject in need thereof.